Bill of Health

APRIL 24, 2023

Dmitry’s talk, “Evergreening: The FDA’s Role in the Creation of Balanced Rights for Pharmaceutical Improvements,” was developed into an article and published in the Iowa Law Review in 2019 titled “The More Things Change: Improvement Patents, Drug Modifications, and the FDA.”

Public Health 313

Public Health FDA Bioethics Governance 313

Bill of Health

NOVEMBER 30, 2022

This post is an adaptation of an article published in the Harvard Social Impact Review. Jackson Women’s Health Organization , overruling almost fifty years of precedent established by Roe v. Food and Drug Administration (FDA) is now top of mind for lawyers, scholars, policymakers, and the public. By Allison M.

FDA 176

FDA Bioethics Public Health Governance 176

Bill of Health

NOVEMBER 3, 2023

PROM responses can be used for purposes of clinical care, research, quality improvement, Food and Drug Administration (FDA) approval of drugs and devices, and even insurance reimbursement. Upon investigation, I found little to no analysis of PROMs in the legal literature, so Andy and I recently published a law review article about them.

Malpractice 284

Malpractice Bioethics HIPAA FDA 284

Bill of Health

JANUARY 7, 2022

Over the summer of 2021, concern grew that the vaccines were not providing the near-perfect protection against symptomatic disease and transmission that had first emboldened the administration to jettison other public health measures. Ultimately, both the FDA and CDC gave their blessing to boosters. In the U.S.,

Public Health 339

Public Health FDA Governance COVID-19 Vaccine 339